Pathogenesis of Hepatic Encephalopathy-with Special Reference to the Roles of Ammonia
Open Access
- 1 May 1970
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 23 (5) , 619-632
- https://doi.org/10.1093/ajcn/23.5.619
Abstract
Hepatic encephalopathy is a clinical syndrome consisting of an abnormal mental and neuromuscular state, liver disease, and characteristic but nonspecific laboratory and electroencephalographic findings. The disorder is classified as a metabolic one since it is often reversible and unaccompained by significant structural changes. It occurs in individuals with liver disease whose brain is apparently sensitive to a variety of toxins and physiologic abnormalities that may summate in their deleterious effect. Of the postulated toxins none has as much evidence in its favor as ammonia. The short-chain fatty acids need further evaluation, however, and it is likely that other, as yet unidentified, toxins may contribute to the induction of hepatic coma. The precise mechanism of the action of toxins on the brain is not known. As regards ammonia, the only likely toxin meaningfully investigated so far, the best guess is that it interferes with maintenance of normal energy stores in the brain, probably at the site of cerebral ammonia detoxication, i.e., at the α-ketoglutarate-glutamate-glutamine level. In acute coma, at least, the brainstem seems the most susceptible site. It should be emphasized that this is a simplified working hypothesis based on fragmentary human data obtained after the establishment of coma and on acute experimental animal models and this presents many dissimilarities from typical human encephalopathy. Perhaps the most vital stimulus to progress in this field would be the development of an animal model of chronic hepatic encephalopathy with more similarity to the clinical condition.Keywords
This publication has 37 references indexed in Scilit:
- CEREBRAL METABOLISM AFTER PORTACAVAL SHUNTThe Lancet, 1969
- Cerebral Blood Flow and Metabolism in the Wernicke-Korsakoff Syndrome*Journal of Clinical Investigation, 1967
- Induction of swelling of liver mitochondria by fatty acids of various chain lengthBiochimica et Biophysica Acta, 1963
- Effect of a Monoamine Oxidase Inhibitor in Experimental Ammonia IntoxicationAnnals of Surgery, 1963
- Mechanism of inhibitory action of ammonia on the respiration of rat-liver mitochondriaBiochimica et Biophysica Acta, 1962
- Preparation from mammallian brain and kidney of the enzyme system involved in active transport of Na+ and K+Biochimica et Biophysica Acta, 1962
- Cerebral metabolism in hepatic insufficiencyThe American Journal of Medicine, 1956
- CYTIDINE AND URIDINE REQUIREMENT OF THE BRAIN*†Journal of Neurochemistry, 1956
- Changes in Free Amino Acids in the Plasma during Hepatic ComaJournal of Clinical Investigation, 1955
- Effects of inhibitors of glutamine synthesis on the inhibition of acetylcholine synthesis in brain slices by ammonium ionsBiochimica et Biophysica Acta, 1953